Clinical trials
Phase 1/2 Burkitt Lymphoma trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 3 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Completed | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| Autolus Limited | 1 |
| Bristol-Myers Squibb | 1 |
| CRISPR Therapeutics AG | 1 |
| Celgene | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Millennium Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Burkitt Lymphoma | 8 |
| Leukemia | 3 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Lymphoma, Non-Hodgkin | 2 |
| Hodgkin Disease | 1 |
| Lymphoma | 1 |
| Lymphoma, B-Cell | 1 |
| Lymphoma, Extranodal NK-T-Cell | 1 |
| Lymphoma, Large-Cell, Anaplastic | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.